5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy (original) (raw)
References
Aasland R, Gibson TJ, Stewart AF . 1995 TIBS20: 56–59
Ammanamanchi S, Brattain MG . 2001 J. Biol. Chem.276: 32854–32859
Aoki A, Suetake I, Miyagawa J, Fujio T, Chijiwa T, Sasaki H, Tajima S . 2001 Nucleic Acids Res.29: 3506–3512
Arapshian A, Kuppumbatti YS, Mira-y-Lopez R . 2000 Oncogene19: 4066–4070
Astuti D, Agathanggelou A, Honorio S, Dallol A, Martinsson T, Kogner P, Cummins C, Neumann HP, Voutilainen R, Dahia P, Eng C, Maher ER, Latif F . 2001 Oncogene20: 7573–7577
Constantinides PG, Jones PA, Gevers W . 1977 Nature267: 364–366
Costello JF, Fruhwald MC, Smiraglia D, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomaki P, Lang JC, Schuller DE, Yu L, Bloomfield CD, Caligiuri MA, Yates A, Nishikawa R, Su Huang H, Petrelli NJ, Zhang X, O'Dorisio MS, Held WA, Cavenee WK, Plass C . 2000 Nat. Genet.24: 132–138
Creusot F, Acs G, Christman JK . 1982 J. Biol. Chem.257: 2041–2048
Daskalakis M, Nuyen TT, Wijermans P . 1999 Blood94: 306a
Davidson S, Crowther P, Radley J, Woodcock D . 1992 Eur. J. Cancer28: 362–368
Dizik M, Christman JK, Wainfan E . 1991 Carcinogenesis12: 1307–1312
Dreijerink K, Braga E, Kuzmin I, Geil L, Duh FM, Angeloni D, Zbar B, Lerman MI, Stanbridge EJ, Minna JD, Protopopov A, Li J, Kashuba V, Klein G, Zabarovsky ER . 2001 Proc. Natl. Acad. Sci. USA98: 7504–7509
Ehrlich M . 2000 DNA Alterations in Cancer, Genetic and Epigenetic Changes Ehrlich M (ed) Eton: Natick, MA pp. 273–291
Esteller M, Corn PG, Baylin SB, Herman JG . 2001 Cancer Res.61: 3225–3229
Fang JY, Zhu SS, Xiao SD, Jiang SJ, Shi Y, Chen XY, Zhou XM, Qian LF . 1996 J. Gastroenterol. Hepatol.11: 1079–1082
Feinberg AP, Gehrke CW, Kuo KC, Ehrlich M . 1988 Cancer Res.48: 1159–1161
Feinberg AP, Vogelstein B . 1987 Semin. Surg. Oncol.3: 149–151
Ferguson AT, Evron E, Umbricht CB, Pandita TK, Chan TA, Hermeking H, Marks JR, Lambers AR, Futreal PA, Stampfer MR, Sukumar S . 2000 Proc. Natl. Acad. Sci. USA97: 6049–6054
Ferguson AT, Lapidus RG, Baylin SB, Davidson NE . 1995 Cancer Res.55: 2279–2283
Flatau E, Gonzales FA, Michalowsky LA, Jones PA . 1984 Mol. Cell. Biol.4: 2098–2102
Friedman S . 1986 Nucleic Acids Res.14: 4543–4556
Fuks F, Burgers WA, Brehm A, Hughes-Davies L, Kouzarides T . 2000 Nat. Genet.24: 88–91
Fuks F, Burgers WA, Godin N, Kasai M, Kouzarides T . 2001 EMBO J.20: 2536–2544
Gabbara S, Bhagwat AS . 1995 Biochem. J.307: 87–92
Gama-Sosa MA, Slagel VA, Trewyn RW, Oxenhandler R, Kuo KC, Gehrke CW, Ehrlich M . 1983 Nucleic Acids Res.11: 6883–6894
García RG, Brank AS, Christman JK, Marquez VE, Eritja R . 2001 Antisense & Nucleic Acid Drug Development11: 369–378
Ghoshal AK, Farber E . 1984 Carcinogenesis5: 1367–1370
Glazer RI, Peale AL, Beisler JA, Abbasi MM . 1980 Mol. Pharmacol.17: 111–117
Glover AB, Leyland-Jones BR, Chun HG, Davies B, Hoth DF . 1987 Cancer Treat. Rep.71: 737–746
Goelz SE, Vogelstein B, Hamilton SR, Feinberg AP . 1985 Science228: 187–190
Gowher H, Jeltsch A . 2001 J. Mol. Biol.309: 1201–1208
Gratchev A, Siedow A, Bumke-Vogt C, Hummel M, Foss HD, Hanski ML, Kobalz U, Mann B, Lammert H, Mansmann U, Stein H, Riecken EO, Hanski C . 2001 Cancer Lett.168: 71–80
Habuchi T, Luscombe M, Elder PA, Knowles MA . 1998 Genomics48: 277–288
Halle S . 1968 J. Virol.2: 1228–1229
Hartsough MT, Clare SE, Mair M, Elkahloun AG, Sgroi D, Osborne CK, Clark G, Steeg PS . 2001 Cancer Res.61: 2320–2327
Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, Markowitz S, Willson JK, Hamilton SR, Kinzler KW, Kane MF, Kolodner RD, Vogelstein B, Kunkel TA, Baylin SB . 1998 Proc. Natl. Acad. Sci. USA95: 6870–6875
Hu JF, Nguyen PH, Pham NV, Vu TH, Hoffman AR . 1997 Mol. Endocrinol.11: 1891–1898
Huynh H, Alpert L, Pollak M . 1996 Cancer Res.56: 4865–4870
Issa JP, Vertino PM, Boehm CD, Newsham IF, Baylin SB . 1996 Proc. Natl. Acad. Sci. USA93: 11757–11762
Izbicka E, MacDonald JR, Davidson K, Lawrence RA, Gomez L, Von Hoff DD . 1999 Anticancer Res.19: 1285–1291
Jackson-Grusby L, Laird PW, Magge SN, Moeller BJ, Jaenisch R . 1997 Proc. Natl. Acad. Sci. USA94: 4681–4685
Jhaveri MS, Morrow CS . 1998 Gene210: 1–7
Jones PA . 1999 Trends Genet.15: 34–37
Jones PA, Taylor SM . 1980 Cell20: 85–93
Jones PA, Wolkowicz MJ, Rideout WM, Gonzales FA, Marziasz CM, Coetzee GA . 1990 Proc. Natl. Acad. Sci. USA87: 6117–6121
Juttermann R, Li E, Jaenisch R . 1994 Proc. Natl. Acad. Sci. USA91: 11797–11801
Kantharidis P, El-Osta A, deSilva M, Wall DM, Hu XF, Slater A, Nadalin G, Parkin JD, Zalcberg JR . 1997 Clin. Cancer Res.3: 2025–2032
Karon M, Benedict WF . 1972 Science178: 62
Karpf AR, Moore BC, Ririe TO, Jones DA . 2001 Mol. Pharmacol.59: 751–757
Kawano S, Miller CW, Gombart AF, Bartram CR, Matsuo Y, Asou H, Sakashita A, Said J, Tatsumi E, Koeffler HP . 1999 Blood94: 1113–1120
Klimasauskas S, Kumar S, Roberts RJ, Cheng X . 1994 Cell76: 357–369
Klimasauskas S, Roberts RJ . 1995 Nucleic Acids Res.23: 1388–1395
Klimasauskas S, Szyperski T, Serva S, Wuthrich K . 1998 EMBO J.17: 317–324
Landolph JR, Jones PA . 1982 Cancer Res.42: 817–823
Salem CE, Markl ID, Bender CM, Gonzales FA, Jones PA, Liang G . 2000 Int. J. Cancer87: 179–185
Santi DV, Norment A, Garrett CE . 1984 Proc. Natl. Acad. Sci. USA81: 6993–6997
Santini V, Kantarjian HM, Issa JP . 2001 Ann. Intern. Med.134: 573–586
Sato S, Yokozaki H, Yasui W, Nikai H, Tahara E . 1999 Jpn. J. Cancer Res.90: 485–489
Sekita N, Suzuki H, Ichikawa T, Kito H, Akakura K, Igarashi T, Nakayama T, Watanabe M, Shiraishi T, Toyota M, Yoshie O, Ito H . 2001 Jpn. J. Cancer Res.92: 947–951
Sharrard RM, Royds JA, Rogers S, Shorthouse AJ . 1992 Br. J. Cancer65: 667–672
Sheikhnejad G, Brank A, Christman JK, Goddard A, Alvarez E, Ford Jr H, Marquez VE, Marasco CJ, Sufrin JR, O'Gara M, Cheng X . 1999 J. Mol. Biol.285: 2021–2034
Shin JY, Kim HS, Park J, Park JB, Lee JY . 2000 Cancer Res.60: 262–265
Shivapurkar N, Poirier LA . 1983 Carcinogenesis4: 1051–1057
Silverman AL, Park JG, Hamilton SR, Gazdar AF, Luk GD, Baylin SB . 1989 Cancer Res.49: 3468–3473